Phylogica (ASX:PYC) is the owner of a peptide library containing the extraordinary richness and diversity of nature. We are using these libraries to develop a drug delivery platform capable of reaching the highest value drug targets located inside cells. Our delivery platform enables drug cargoes to cross the cell membrane and directly reach their target.
16 July 2018: Phylogica is pleased to announce that its manuscript on methods for evaluating the performance of Cell Penetrating Peptides (CPPs) has been published in the peer reviewed journal Biomolecules. The publication is part of a special issue devoted to CPPs demonstrating the growing interest in this field.
For further information please download PDF attached:
Download this document
